2024 annual financial data

Eton Pharmaceuticals 2024 Financial results

Direct answer

Revenue was 39.01M USD.

Operating income was -2.6M USD and net income was -3.82M USD.
Operating cash flow was 969,000 USD.

Get free Eton Pharmaceuticals email updates.

Bullstory sends one daily email when new analysis or important company news is available.

Verified data

Revenue
39.01M USD
Operating income
-2.6M USD
Net income
-3.82M USD
Operating cash flow
969,000 USD